Cure My Disease

Don't miss your cure!

 Log in / Sign up

10-Year study tracks safety of silimed smooth breast implants

NCT ID NCT05345821

Recruiting now Disease control Sponsor: Silimed Industria de Implantes Ltda Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study follows 384 women receiving Silimed smooth surface breast implants for augmentation over 10 years. Researchers will track complications and patient satisfaction to evaluate the implant's safety and performance. Participants must be 18 or older and seeking breast enlargement for the first time or as a revision.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Silimed smooth surface breast implant
What this could lead to
If successful, this study could confirm that Silimed smooth breast implants are safe and effective for breast augmentation, providing reliable data for patients and doctors.
What could go wrong
This is an observational post-market study, not a controlled trial, so results may not prove cause and effect. Long-term risks like rupture or capsular contracture remain possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST IMPLANT; COMPLICATIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Personal Satisfaction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST IMPLANT; COMPLICATIONS QUALITY OF LIFE SAFETY AND PERFORMANCE SATISFACTION

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Fundação do ABC - Centro universitário FMABC

    RECRUITING

    Santo André, São Paulo, 09060-870, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.